NEUROTOUCH

Owner

Goods & Services

Biotechnology research and development; neurological, pharmaceutical, and genetic research and development; drug discovery, design, and research and development; research and development relating to ion channel modulators, neuradegenerative diseases, analgesics and pain control; neuropsychological and diagnostic testing, research, and development; consultancy services relating to all the aforesaid

Apparatus and instruments for cognitive, psychological, and neuropsychological testing, diagnosis, and treatment; medical apparatus and instruments, namely, screening instrumentation for electrophysiological testing; operant chambers for animal testing; and parts and fittings for all the aforesaid

Computer hardware; experimental apparatus and instrumentation, and computer software and hardware for cognitive, psychological and neuropsychological testing; cognition and neuropsychological testing systems employing visual tests displayed on a computer screen for testing humans and animals; scientific and laboratory apparatus and instruments for electrophysiology applications; computer software controlling cognitive psychological and neuropsychological testing apparatus, scientific and laboratory apparatus and instruments for electrophysiology applications, and operant chambers for animal testing; database management software and electronic databases in the field of cognitive, psychological, and neuropsychological testing recorded on computer media; clinical assessment software, hardware, experimental apparatus, and instrumentation; touch screen apparatus for all the aforesaid; and parts and fittings for all the aforesaid

Drugs for the management of pain and related conditions; pain control drugs; drugs for the treatment of neurodegeneractive diseases and neurological and psychiatric disorders; drugs affecting psychological and motor performance; drugs for use in connection with drug abuse; analgesics; and ion channel modulators